Market Place
Sourcing Support
Laurent Receives Health Canada’s Approval to Initiate Ph 2/3 Trial in Long COVID
29 Aug 2023 //
BUSINESSWIRE
Laurent Pharmaceuticals Presents Results from Phase 2 Clinical Study of LAU-7b
03 Nov 2022 //
BUSINESSWIRE
Laurent Pharma Starts Phase 3 Study With Once-a-Day Oral COVID-19 Antiviral Drug
15 Feb 2022 //
BUSINESSWIRE
Laurent Extends COVID-19 Phase 2 Study with Oral Antiviral LAU-7b
15 Dec 2021 //
BUSINESSWIRE
Laurent’s LAU-7b fails to meet primary goal in Phase II Covid-19 trial
04 Oct 2021 //
CLINICALTRIALSARENA
Laurent Announces Topline Results from its Phase 2 RESOLUTION Trial of LAU-7b
30 Sep 2021 //
BUSINESSWIRE
Laurent`s COVID oral therapy fails in hospitalized patient trial
30 Sep 2021 //
FIERCEBIOTECH
Laurent Pharma Completes Enrollment in Phase 2 Study of LAU-7b
20 May 2021 //
BUSINESSWIRE
Laurent to continue study of LAU-7b in Covid-19 patients
09 Apr 2021 //
CLINICALTRIALSARENA
Laurent to continue study of LAU-7b in Covid-19 patients
08 Apr 2021 //
CLINICALTRIALSARENA
Laurent Pharma Initiates Phase II Trial of LAU-7b in COVID-19 Disease
27 Aug 2020 //
CONTRACTPHARMA
Laurent Receives Approval from FDA to Initiate its COVID-19 Ph 2 Clinical Trial
26 Aug 2020 //
PRNEWSWIRE
Laurent Pharmaceuticals Joins Battle Against COVID-19
09 Apr 2020 //
BUSIBNESSWIRE
Laurent Pharmaceuticals Receives CAD 2.7M Financing from BioMed Propulsion
04 Dec 2019 //
BUSINESS WIRE
Laurent Pharmaceuticals Receives an Additional up to $3M Award
31 Oct 2019 //
BUSINESSWIRE
Copyright © 2024 LePro PharmaCompass OPC Private Limited, All rights reserved.